Emerald Advisers’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,726
| Closed | -$762K | – | 253 |
|
|
2024
Q1 | $762K | Sell |
8,726
-5,724
| -40% | -$500K | 0.03% | 157 |
|
|
2023
Q4 | $1.39M | Buy |
14,450
+1,908
| +15% | +$184K | 0.06% | 137 |
|
|
2023
Q3 | $1.11M | Buy |
12,542
+1,978
| +19% | +$175K | 0.05% | 141 |
|
|
2023
Q2 | $916K | Buy |
10,564
+1,768
| +20% | +$153K | 0.04% | 148 |
|
|
2023
Q1 | $855K | Sell |
8,796
-49
| -0.6% | -$4.77K | 0.04% | 150 |
|
|
2022
Q4 | $915K | Buy |
+8,845
| New | +$915K | 0.04% | 141 |
|